Increasing Health Care System Participation in Research Requires New Support Systems
DCRI Executive Director Adrian Hernandez, MD, MHS, and co-authors recently published a commentary in the New England Journal of Medicine advocating for new ways to incentivize health care systems t
Report Shows that N.C. K-12 Schools Reopened Safely, Paving the Way for Schools Nationwide to Limit COVID-19 Spread in the Classroom
Top scientists and physicians from the ABC Science Collaborative have shared insights from North Carolina schools, coupled with a science-based blueprint for all schools to resume full, in-person i
DCRI and HumanFirst Collaborate to Improve Scientific Rigor for Digital Measures
The new Digital Measures Evaluation Center will evaluate digital sensors and other measures, a critical step to ensure products are evaluated for both accuracy and equity.
Randomized, Pragmatic Trial Testing Antimicrobial Therapy for Treatment of Idiopathic Pulmonary Fibrosis Shows No Significant Effect
What ADAPTABLE Has Taught Us
Following the presentation of results from DCRI’s ADAPTABLE
ACC 2021: CONNECT-HF Provides New Data on Heart Failure Quality Improvement
ACC 2021: ACTION Trial Shows Oral Anticoagulation with Rivaroxaban Does Not Help Patients With COVID-19
The investigators found no significant benefit to patient outcomes when examining time to death, duration of hospitalization, or duration of supplemental oxygen.
ACC 2021: ADAPTABLE Answers the Aspirin Question, Provides Framework for Novel Research Methods
The results provide insight into which dose may be best for most patients.